Fibrinogen availability and coagulation function after hemorrhage and resuscitation in pigs

Molecular Medicine

Volumn 17, Issue 7-8, 2011, Pages 757-761

  Martini, Wenjun ^a  

^a US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; FIBRINOGEN; LACTIC ACID; PROTHROMBIN; RINGER LACTATE SOLUTION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TIME; BLOOD SAMPLING; BLOOD VOLUME; CONTROLLED STUDY; FIBRINOGEN BLOOD LEVEL; HEART OUTPUT; HEART RATE; HEMODYNAMICS; HEMORRHAGIC SHOCK; HEMOSTASIS; MEAN ARTERIAL PRESSURE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; RESUSCITATION; SWINE; THROMBOCYTE COUNT; THROMBOELASTOGRAPHY;

ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; BLOOD PRESSURE; BREEDING; FEMALE; FIBRINOGEN; ISOTONIC SOLUTIONS; MALE; PARTIAL THROMBOPLASTIN TIME; PLATELET COUNT; PROTHROMBIN TIME; RANDOM ALLOCATION; RESUSCITATION; SHOCK, HEMORRHAGIC; SWINE; THROMBELASTOGRAPHY; TIME FACTORS;

EID: 79960720528     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2010.00093     Document Type: Article

References (24)

1. Mann KG, Brummel K, Butenas S. (2003) What is all that thrombin for? J. Thromb. Haemost. 1:1504-14.
2. Hoffman M, Monroe DM 3rd. (2001) A cellbased model of hemostasis. Thromb. Haemost. 85:958-65.
3. Stahel PF, Moore EE, Schreier SL, Flierl MA, Kashuk JL. (2009) Transfusion strategies in postinjury coagulopathy. Curr. Opin. Anaesthesiol. 22:289-98.
4. Cotton BA, et al. (2008) Damage control hematology: the impact of a trauma exsanguination protocol on survival and blood product utilization. J. Trauma. 64:1177-82; discussion 1182-3.
5. Stinger HK, et al. (2008) The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J. Trauma. 64:S79-85; discussion S85.
6. Schochl H, et al. (2010) Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit. Care. 14:R55.
7. Danes AF, Cuenca LG, Bueno SR, Mendarte Barrenechea L, Ronsano JB. (2008) Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency and active or in higH-risk severe bleeding. Vox Sang. 94:221-6.
8. Fenger-Eriksen C, et al. (2009) Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. J. Thromb. Haemost. 7:795-802.
9. Schick KS, Fertmann JM, Jauch KW, Hoffmann JN. (2009) Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding. Crit. Care. 13:R191.
10. Bruce D, Nokes TJ. (2008) Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital. Crit. Care. 12:R105.
11. Kettner SC, et al. (1999) Use of abciximabmodified thrombelastography in patients undergoing cardiac surgery. Anesth. Analg. 89:580-4.
12. Ereth MH, et al. (1997) Does the platelet-activated clotting test (HemoSTATUS) predict blood loss and platelet dysfunction associated with cardiopulmonary bypass? Anesth. Anal. 85:259-64.
13. Gottumukkala VN, Sharma SK, Philip J. (1999) Assessing platelet and fibrinogen contribution to clot strength using modified thromboelastography in pregnant women. Anesth. Anal. 89:1453-5.
14. Plotkin AJ, et al. (2008) A reduction in clot formation rate and strength assessed by thrombelastography is indicative of transfusion requirements in patients with penetrating injuries. J. Trauma. 64:S64-8.
15. Nuttall GA, et al. (2001) Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology. 94:773-81; discussion 775A-776A.
16. Shore-Lesserson L, et al. (1999) Thromboelastography- guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth. Anal. 88:312-9.
17. Li YF, Spencer FA, Becker RC. (2001) Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa (alphaIIb/beta3) receptor-directed platelet inhibition. Am. Heart J. 142:204-10.
18. Lang T, et al. (2009) The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth. Anal. 108:751-8.
19. Velik-Salchner C, et al. (2007) The effect of fibrinogen concentrate on thrombocytopenia. J. Thromb. Haemost. 5:1019-25.
20. Charbit B, et al. (2007) The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J. Thromb. Haemost. 5:266-73.
21. Cuthbertson DP, Tompsett SL. (1935) Note on the effect of injury on the level of the plasma proteins. Br. J. Exp. Pathol. 16:471-5.
22. Clowes GH, Jr., Randall HT, Cha CJ. (1980) Amino acid and energy metabolism in septic and traumatized patients. JPEN J. Parenter. Enteral Nutr. 4:195-205.
23. Jahoor F, Desai M, Herndon DN, Wolfe RR. (1988) Dynamics of the protein metabolic response to burn injury. Metabolism. 37:330-7.
24. Fleck A. (1989) Clinical and nutritional aspects of changes in acute-phase proteins during inflammation. Proc. Nutr. Soc. 48:347-54.